ARTICLE | Clinical News
AVT-02 UE: Phase I data
June 23, 2008 7:00 AM UTC
In a double-blind, placebo-controlled, German Phase I trial in 20 healthy male volunteers, AVT-02 UE was well tolerated. There were no substantial changes of the skin physiology parameters and laborat...